An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
De Giorgi R. et al, (2025), Nature Mental Health
Preliminary evidence should be treated as such: Response to "Is creatine useful as adjuvant in cognitive-behavioural therapy for depression?".
De Giorgi R. et al, (2025), Eur Neuropsychopharmacol, 93, 15 - 16
Acute angiotensin receptor blockade and mnemonic discrimination in healthy participants.
Prasad D. et al, (2025), J Affect Disord
Real-world effects of antidepressants for depressive disorder in primary care: population-based cohort study.
De Crescenzo F. et al, (2024), Br J Psychiatry, 1 - 10
Efficacy and safety profile of oral creatine monohydrate in add-on to cognitive-behavioural therapy in depression: An 8-week pilot, double-blind, randomised, placebo-controlled feasibility and exploratory trial in an under-resourced area.
Sherpa NN. et al, (2024), Eur Neuropsychopharmacol, 90, 28 - 35
Prevalence of Antidepressant Prescriptions for Community-Dwelling Adults Diagnosed with Depressive Disorder in the UK: A Systematic Review
Francia L. et al, (2024), Psychiatric Quarterly
12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study
DE GIORGI R., (2024), EClinicalMedicine
Treatment coverage for depression in the general Spanish population and the impact of the Covid-19 pandemic
Francia L. et al, (2024), Heliyon, 10, e32594 - e32594
Mortality and adverse events associated with statin use in primary care patients with depression: a real-world, population-based cohort study
DE GIORGI R. et al, (2024), BMJ Mental Health
Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study.
De Giorgi R. et al, (2023), BMC Med, 21
The pharmacological bases for repurposing statins in depression: a review of mechanistic studies.
De Giorgi R. et al, (2023), Transl Psychiatry, 13
Setting national research priorities for difficult-to-treat depression in the UK between 2021-2026.
Chapman N. et al, (2022), J Glob Health, 12
Statins in depression: a repurposed medical treatment can provide novel insights in mental health
De giorgi R., (2022), International Review of Psychiatry
The effects of statin monotherapy on depressive symptoms: A systematic review and meta-analysis.
De Giorgi R. et al, (2022), J Affect Disord, 311, 336 - 343
An experimental medicine study of the effects of simvastatin on emotional processing, reward learning, verbal memory, and inflammation in healthy volunteers.
De Giorgi R. et al, (2022), Psychopharmacology (Berl)
Effects of various statins on depressive symptoms: is there enough evidence?
De Giorgi R. et al, (2021), Journal of Affective Disorders, 295, 1093 - 1094
The effects of atorvastatin on emotional processing, reward learning, verbal memory, and inflammation in healthy volunteers: an experimental medicine study
DE GIORGI R. et al, (2021), Journal of Psychopharmacology